IL6 and rheumatoid arthritis: Encouragingly, therefore, in consideration of the route to the clinic, our early preliminary data suggest that ES-62 and 11a but not 12b can inhibit LPS-stimulated IL-6 production from PBMC from RA patients and also that (at least) ES-62 can similarly reduce IL-17 production.